AAOS Annual Meeting 2022: M8 at the forefront

05 April 2022 - Trade fairs & Congresses -

New opportunities to present ASA devices arrive from the United States, where the company, thanks to a stand set up by OrthoLazer Orthopedic Laser Centers (in cooperation with the local distributor Cutting Edge Laser Technologies), saw its M8 robotic device in the spotlight during the annual meeting of the American Association of Orthopedic Surgeons (AAOS).

“This meeting – explains Lucio Zaghetto, the President of ASA and Sales Manager for all of North America – was an important event for the industry in the years before the pandemic, attracting an average of 30,000 visitors. This year, there were around 6,000 visitors: there is no doubt that there has been a sharp drop in attendance compared to previous years, but the trend is certainly positive”.

This positive trend was also confirmed by the number of professionals who visited the OrthoLazer exhibition space, showing a real interest in learning more about the benefits of MLS® Laser Therapy and the uses of M8.

“We were able to discuss these uses also by meeting Dr. Scott Sigman, an orthopaedic surgeon from Massachusetts, founder of OrthoLazer and pioneer in the use of this device not only in his field. In fact, the luminary has also used it successfully to treat interstitial pneumonia caused by COVID-19 in a clinical trial in the United States. The patients affected by the virus, subjected to MLS® Laser Therapy saw significant improvements in several parameters including respiratory rates and blood oxygenation”.

ASA's participation at the Meeting in Chicago was therefore a success, also thanks to the growing interest of private equity companies specialising in the industry, interested in acquiring therapy centres and orthopaedic hospitals, for which to develop multi-year investment and growth plans.

“This possibility, which emerged during the 4th Annual Physicians Transactions Conference, organised as part of the AAOS event, if it takes shape, may certainly pave the way for new development channels that should not be underestimated”, concludes Zaghetto.

You might also be interested in ...

See all articles

ASA laser devices at Kimes 2022
news - 17/03/2022
During the “Korea International Medical & Hospital Equipment Show” (Seoul, 10-13 March 2022), co-protagonists at the Asian Star stand (ASA local distributor) were M6 and MiS, which joined HIRO 3....
AAOS practice guideline knee osteoarthritis
blog - 22/09/2021
This therapy can be concretely effective for treating both acute and chronic knee pain, as it reduces the inflammation and leads to faster healing, in addition to promoting tissue regrowth and to...
M8 laser treatment for pain due to COVID-19
blog - 09/04/2021
The results actually showed that patients undergoing MLS® Laser Therapy had a rapid recovery
2024 ASAlaser activities
News - 11/12/2024
Whether it’s by taking part in Congresses and Fairs or organising on-site courses or webinars, once again in 2024 ASA has proved to be highly proactive in both the human and veterinary fields.
El.En. e ASA unite nello sviluppo tecnologico
News - 09/12/2024
Research and Development are the pillars on which all the companies of the El.En. Group base their growth: technological innovation, continuous training and know-how sharing are the key words that...
MLS Laser Therapy Workshop @ Melbourne
News - 28/11/2024
Two days of analysis and seminars focused on MLS® Laser Therapy with the support of laser therapy authorities.